Huntsman Corporation
NYSE:HUNChemicals
-$0.46 today
- Market cap
- $1.58B
- Beta
- 0.66
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.87
- Dividend yield
- 4.18%
Volume 3.62M
Average 5.21M
HUN Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Huntsman CorporationNYSE: HUN
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI remains negative
Q1 FY2026 Accumulated OCI was -$1.02B, compared with -$1.17B a year earlier.
Context
- Accumulated OCI amounted to 14.3% of total assets at the end of Q1 FY2026, down 1.9 pp from a year earlier.
- Accumulated OCI grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +12.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (1.01B) USD
- Year-over-year change
- +16.2%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.01B) | +16.2% |
| FY2024 | 2024-12-31 | (1.2B) | +3.6% |
| FY2023 | 2023-12-31 | (1.25B) | +1.8% |
| FY2022 | 2022-12-31 | (1.27B) | -5.4% |
| FY2021 | 2021-12-31 | (1.2B) | — |
Accumulated OCI vs competitors
How HUN compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +12.9% is the 6th highest of 10, against a peer median of +21.8%.
- Accumulated OCI amounts to 14.3% of total assets for HUN, versus a peer median of 2.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $232.36M USD | +1634.7% | +305.5% | 15.9% | |
| Jan 2026 | CA$112.13M CAD | +197.4% | +32.6% | 11.0% | |
| Dec 2025 | $44.26M USD | -56.9% | +40.5% | 16.6% | |
| Jun 2026 | $35.56M USD | +66.5% | -4.6% | 1.9% | |
| Jun 2026 | $9.7M USD | -64.3% | +103.1% | 0.3% | |
| Dec 2025 | $8.87M USD | +919.8% | -33.2% | 6.9% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | -$2.66M USD | -167.6% | +115.2% | 0.5% | |
| Jun 2026 | -$229M USD | +21.8% | — | 3.2% | |
| Mar 2026 | -R$824.76M BRL | -154.0% | — | 1.1% | |
| Mar 2026 | -$1.02B USD | +12.9% | — | 14.3% | |
| Peer median (excluding HUN) | — | +21.8% | +40.5% | 2.5% | |
Competitors are the stored peer set for HUN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.04B | 654M | 540M | 340M | 429M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.35B | 834M | 753M | 725M | 677M |
| Inventory | 1.04B | 995M | 867M | 917M | 818M |
| Other Current Assets | 501M | 662M | 62M | 29M | 46M |
| Total Current Assets | 3.93B | 3.15B | 2.31B | 2.13B | 2.06B |
| Property, Plant & Equipment (Net) | 2.82B | 2.75B | 2.74B | 2.88B | 2.85B |
| Goodwill | 650M | 641M | 644M | 633M | 630M |
| Intangible Assets | 469M | 425M | 387M | 344M | 308M |
| Long-term Investments | 470M | 425M | 438M | 346M | 309M |
| Tax Assets | 180M | 147M | 112M | 69M | 49M |
| Other Non-current Assets | 871M | 686M | 611M | 722M | 804M |
| Total Non-current Assets | 5.46B | 5.08B | 4.93B | 4.99B | 4.95B |
| Total Assets | 9.39B | 8.22B | 7.25B | 7.11B | 7.02B |
| Account Payables | 1.11B | 961M | 719M | 770M | 721M |
| Short-term Debt | 12M | 66M | 12M | 325M | 410M |
| Tax Payables | 184M | 112M | 116M | 117M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 163M | 194M | 0 | 338M | 349M |
| Total Current Liabilities | 2.05B | 1.7B | 1.17B | 1.57B | 1.59B |
| Long-term Debt | 1.54B | 1.67B | 1.68B | 1.51B | 1.99B |
| Deferred Tax Liabilities | 161M | 250M | 243M | 204M | 156M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 737M | 422M | 345M | 324M | (11M) |
| Total Non-current Liabilities | 2.78B | 2.68B | 2.6B | 2.39B | 2.47B |
| Total Liabilities | 4.83B | 4.38B | 3.77B | 3.95B | 4.06B |
| Common Stock | 3M | 3M | 3M | 3M | 3M |
| Retained Earnings | 2.44B | 2.71B | 2.62B | 2.25B | 1.81B |
| Accumulated OCI | (1.2B) | (1.27B) | (1.25B) | (1.2B) | (1.01B) |
| Other Stockholders Equity | (25M) | (35M) | (41M) | (32M) | (28M) |
| Minority Interest | 181M | 216M | 227M | 204M | 207M |
| Total Equity | 4.56B | 3.84B | 3.48B | 3.16B | 2.96B |
| Total Debt | 1.95B | 2.12B | 2.07B | 2.24B | 2.73B |
| Net Debt | 904M | 1.47B | 1.53B | 1.9B | 2.31B |
Huntsman Corporation
NYSE:HUN
Intrinsic Alpha fair value
Locked
Current Price
$9.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.